JPMorgan Reaffirms Overweight Rating on Siemens Healthineers Stock

Siemens Healthineers stock (ISIN DE000SHL1006) has received fresh analyst support from JPMorgan, which reaffirmed its Overweight rating on September 9, 2026. The shares were trading near EUR 38.61 on Xetra, a fraction above the EUR 38.55 level recorded on September 4, 2026.

JPMorgan's analysts remain cautious about the broader European medtech sector but see Siemens Healthineers as relatively well positioned. This view is reflected in the company's Overweight rating, which was also maintained in August when JPMorgan initially rated the stock Overweight on August 3, 2026.

The analyst landscape for Siemens Healthineers also includes a Buy rating from Jefferies dated August 4, 2026. However, no explicit price target is listed for this rating.